Increased antibiotic release from a bone cement containing bacterial cellulose.

Area of Science:

• Biomaterials science
• Orthopedic surgery
• Drug delivery systems

Background:

• Traditional antibiotic bone cements suffer from compromised mechanical strength and limited drug release when high antibiotic doses are incorporated.
• Bacterial cellulose, a unique hydrophilic mesh, presents potential for sustained antibiotic elution.
• This study investigates the integration of bacterial cellulose into antibiotic bone cement to address these limitations.

Purpose of the Study:

• To evaluate the mechanical properties and antibiotic release kinetics of a novel cellulose-based antibiotic bone cement.
• To compare the performance of cellulose antibiotic cement against plain cement and conventional antibiotic cement.

Main Methods:

• High-dose antibiotics were incorporated into bacterial cellulose and subsequently mixed with bone cement.
• Compression strength, fracture toughness, and fatigue life were assessed.
• Antibiotic elution kinetics were measured over 35 days.

Main Results:

• Cellulose antibiotic cement retained 97% compression strength and 97% fracture toughness compared to plain cement, significantly outperforming traditional antibiotic cement (79% and 82%, respectively).
• Fatigue life was improved to 78% of plain cement values, compared to only 17% for traditional antibiotic cement.
• Cumulative antibiotic elution was 129% greater from cellulose antibiotic cement than from traditional antibiotic cement over 35 days.

Conclusions:

• Incorporating bacterial cellulose into antibiotic bone cement mitigates mechanical degradation and enhances antibiotic elution, even at high doses.
• This improved formulation preserves mechanical integrity and increases drug release, suggesting significant clinical potential.
• Cellulose antibiotic cements are promising for applications demanding both robust mechanical performance and sustained, high-level antibiotic delivery.